Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Aromatase inhibitors for breast cancer: proven efficacy across the spectrum of disease.

Herold CI, Blackwell KL.

Clin Breast Cancer. 2008 Feb;8(1):50-64. doi: 10.3816/CBC.2008.n.003. Review.

PMID:
18501059
2.

The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics.

Awada A, Cardoso F, Fontaine C, Dirix L, De Grève J, Sotiriou C, Steinseifer J, Wouters C, Tanaka C, Zoellner U, Tang P, Piccart M.

Eur J Cancer. 2008 Jan;44(1):84-91. Epub 2007 Nov 26.

PMID:
18039566
3.
4.

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

Glass AG, Lacey JV Jr, Carreon JD, Hoover RN.

J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. Epub 2007 Jul 24.

5.

The decrease in breast-cancer incidence in 2003 in the United States.

Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA.

N Engl J Med. 2007 Apr 19;356(16):1670-4.

6.

Men with breast cancer have high risk of second cancer.

Bagchi S.

Lancet Oncol. 2007 Mar;8(3):198. No abstract available.

PMID:
17348113
7.

Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.

Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M; American Heart Association Nutrition Committee.

Circulation. 2006 Feb 21;113(7):1034-44. Epub 2006 Jan 17.

9.

Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.

Koeberle D, Thuerlimann B.

Expert Rev Anticancer Ther. 2006 Jan;6(1):5-10. Review.

PMID:
16375638
10.

Defining the roles of aromatase inhibitors in the adjuvant treatment of early-stage breast cancer.

Howell A, Locker GY.

Clin Breast Cancer. 2005 Oct;6(4):302-9. Review.

PMID:
16277879
11.

Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study.

Kaari C, Haidar MA, Júnior JM, Nunes MG, Quadros LG, Kemp C, Stavale JN, Baracat EC.

Maturitas. 2006 Jan 10;53(1):49-58. Epub 2005 Oct 27.

PMID:
16257151
12.

Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review.

Gerber B, Scholz C, Reimer T, Briese V, Janni W.

Breast Cancer Res Treat. 2006 Feb;95(3):199-209. Review.

PMID:
16254687
13.

Maintenance hormone therapy with letrozole after first-line chemotherapy for advanced breast cancer.

Bertelli G, Garrone O, Bertolotti L, Occelli M, Conforti S, Marzano N, Febbraro A, Carlini P, Liossi C, Del Mastro L, Leonard RC.

Oncology. 2005;68(4-6):364-70. Epub 2005 Jul 11.

PMID:
16020964
14.

Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.

Brooks JD, Thompson LU.

J Steroid Biochem Mol Biol. 2005 Apr;94(5):461-7. Epub 2005 Mar 16.

PMID:
15876411
15.

Isoflavones and postmenopausal women: a critical review.

Phipps WR, Duncan AM, Kurzer MS.

Treat Endocrinol. 2002;1(5):293-311. Review.

PMID:
15832484
16.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS; ATAC Trialists' Group.

Lancet. 2005 Jan 1-7;365(9453):60-2.

PMID:
15639680
17.
18.

Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover).

Roberts DW, Doerge DR, Churchwell MI, Gamboa da Costa G, Marques MM, Tolleson WH.

J Agric Food Chem. 2004 Oct 20;52(21):6623-32.

PMID:
15479032
19.

Organization of the human aromatase p450 (CYP19) gene.

Bulun SE, Takayama K, Suzuki T, Sasano H, Yilmaz B, Sebastian S.

Semin Reprod Med. 2004 Feb;22(1):5-9. Review.

PMID:
15083376
20.

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, Coates AS, Bajetta E, Dodwell D, Coleman RE, Fallowfield LJ, Mickiewicz E, Andersen J, Lønning PE, Cocconi G, Stewart A, Stuart N, Snowdon CF, Carpentieri M, Massimini G, Bliss JM, van de Velde C; Intergroup Exemestane Study.

N Engl J Med. 2004 Mar 11;350(11):1081-92. Erratum in: N Engl J Med. 2004 Dec 2;351(23):2461. N Engl J Med. 2006 Oct 19;355(16):1746. van de Velde, Cornelius [added].

Items per page

Supplemental Content

Write to the Help Desk